Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC. |  |
|
| PresidentMr. Michael Amoroso CFO & Principal Accounting OfficerMr. John Alexander Kelly R.Ph. General Counsel & SecretaryMr. Dario Scimeca J.D. Co-Founder & Chief Research OfficerDr. Jefferson J. Smith Ph.D. Chief Scientific OfficerDr. Cassie Gorsuch Ph.D. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Amoroso Michael | President and CEO | Feb 17 '26 | Option Exercise | 0.00 | 67,797 | 0 | 263,951 | Feb 19 04:31 PM | | Amoroso Michael | President and CEO | Feb 18 '26 | Sale | 3.84 | 20,559 | 78,947 | 243,392 | Feb 19 04:31 PM | | Kelly John Alexander | Chief Financial Officer | Feb 17 '26 | Option Exercise | 0.00 | 27,584 | 0 | 134,032 | Feb 19 04:31 PM | | Kelly John Alexander | Chief Financial Officer | Feb 18 '26 | Sale | 3.84 | 8,149 | 31,292 | 125,883 | Feb 19 04:31 PM | | Scimeca Dario | General Counsel and Secretary | Feb 17 '26 | Option Exercise | 0.00 | 16,667 | 0 | 61,382 | Feb 19 04:30 PM | | Scimeca Dario | General Counsel and Secretary | Feb 18 '26 | Sale | 3.84 | 4,925 | 18,912 | 56,457 | Feb 19 04:30 PM | | SMITH J. JEFFERSON | Chief Research Officer | Feb 17 '26 | Option Exercise | 0.00 | 16,667 | 0 | 126,851 | Feb 19 04:30 PM | | SMITH J. JEFFERSON | Chief Research Officer | Feb 18 '26 | Sale | 3.84 | 4,925 | 18,912 | 121,926 | Feb 19 04:30 PM | | SMITH J. JEFFERSON | Officer | Feb 18 '26 | Proposed Sale | 3.84 | 4,925 | 18,929 | | Feb 18 05:05 PM | | Scimeca Dario | Officer | Feb 18 '26 | Proposed Sale | 3.84 | 4,925 | 18,929 | | Feb 18 04:31 PM | | Amoroso Michael | Officer | Feb 18 '26 | Proposed Sale | 3.84 | 20,559 | 79,019 | | Feb 18 04:30 PM | | Kelly John Alexander | Officer | Feb 18 '26 | Proposed Sale | 3.84 | 8,149 | 31,321 | | Feb 18 04:19 PM | | Amoroso Michael | President and CEO | Jan 22 '26 | Sale | 4.17 | 34,799 | 145,112 | 196,154 | Jan 22 06:49 PM | | Scimeca Dario | General Counsel and Secretary | Jan 20 '26 | Option Exercise | 0.00 | 25,311 | 0 | 53,569 | Jan 22 06:48 PM | | Scimeca Dario | General Counsel and Secretary | Jan 21 '26 | Sale | 4.03 | 8,854 | 35,682 | 44,715 | Jan 22 06:48 PM | | Kelly John Alexander | Chief Financial Officer | Jan 21 '26 | Sale | 4.03 | 15,213 | 61,308 | 106,448 | Jan 22 06:48 PM | | SMITH J. JEFFERSON | Chief Research Officer | Jan 21 '26 | Sale | 4.03 | 10,200 | 41,106 | 110,184 | Jan 22 06:48 PM | | Amoroso Michael | Officer | Jan 22 '26 | Proposed Sale | 4.17 | 34,799 | 145,202 | | Jan 22 03:19 PM | | Scimeca Dario | Officer | Jan 21 '26 | Proposed Sale | 4.03 | 8,854 | 35,653 | | Jan 21 04:19 PM | | SMITH J. JEFFERSON | Officer | Jan 21 '26 | Proposed Sale | 4.03 | 10,200 | 41,073 | | Jan 21 04:14 PM | | Kelly John Alexander | Officer | Jan 21 '26 | Proposed Sale | 4.03 | 15,213 | 61,260 | | Jan 21 04:07 PM | | Germano Geno J | Director | Dec 16 '25 | Buy | 4.72 | 3,000 | 14,160 | 23,883 | Dec 17 07:02 AM | | Frankel Stanley | Director | Dec 16 '25 | Buy | 4.70 | 2,700 | 12,690 | 19,478 | Dec 17 07:01 AM | | Brown Melinda | Director | Dec 15 '25 | Buy | 4.97 | 1,381 | 6,864 | 23,346 | Dec 17 07:00 AM | | Kelly John Alexander | Chief Financial Officer | Nov 02 '25 | Option Exercise | 0.00 | 3,605 | 0 | 78,601 | Nov 04 04:15 PM | | Kelly John Alexander | Chief Financial Officer | Nov 03 '25 | Sale | 6.49 | 1,303 | 8,456 | 77,298 | Nov 04 04:15 PM | | Scimeca Dario | General Counsel and Secretary | Nov 02 '25 | Option Exercise | 0.00 | 1,835 | 0 | 28,923 | Nov 04 04:15 PM | | Scimeca Dario | General Counsel and Secretary | Nov 03 '25 | Sale | 6.49 | 665 | 4,316 | 28,258 | Nov 04 04:15 PM | | Amoroso Michael | President and CEO | Nov 02 '25 | Option Exercise | 0.00 | 9,444 | 0 | 118,984 | Nov 04 04:15 PM | | Amoroso Michael | President and CEO | Nov 03 '25 | Sale | 6.49 | 3,409 | 22,124 | 115,575 | Nov 04 04:15 PM | | Kelly John Alexander | Officer | Nov 03 '25 | Proposed Sale | 6.49 | 1,303 | 8,455 | | Nov 03 03:16 PM | | Amoroso Michael | Officer | Nov 03 '25 | Proposed Sale | 6.49 | 3,409 | 22,121 | | Nov 03 03:15 PM | | Scimeca Dario | Officer | Nov 03 '25 | Proposed Sale | 6.49 | 665 | 4,315 | | Nov 03 03:07 PM | | Frankel Stanley | Director | Sep 26 '25 | Buy | 4.97 | 2,700 | 13,419 | 16,778 | Sep 30 07:00 AM | | Brown Melinda | Director | Sep 22 '25 | Buy | 4.89 | 1,400 | 6,846 | 21,965 | Sep 24 07:00 AM |
|
